Cite
HARVARD Citation
Mahanta, S. et al. (2022). Novel Levilactobacillus brevis-based formulation for controlling cell proliferation, cell migration and gut dysbiosis. Lebensmittel-Wissenschaft + Technologie =. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mahanta, S. et al. (2022). Novel Levilactobacillus brevis-based formulation for controlling cell proliferation, cell migration and gut dysbiosis. Lebensmittel-Wissenschaft + Technologie =. p. . [Online].